En-Qiang Chen
Overview
Explore the profile of En-Qiang Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou J, Wang F, Li L, Li Y, Wang S, Chen E
Trials
. 2024 Oct;
25(1):652.
PMID: 39363218
Background: Direct high-quality evidence remains absent on the benefits of HBeAg-negative chronic hepatitis B patients (CHB) with normal alanine transaminase (ALT) and positive HBV DNA after nucleos(t)ide analogs (NAs) treatment....
2.
Wang Y, Tang H, Chen E
Viruses
. 2024 Apr;
16(4).
PMID: 38675872
Hepatitis B virus (HBV) infection is a serious global health problem, and chronic HBV infection significantly increases the risk of liver fibrosis, cirrhosis, and even hepatocellular carcinoma in patients. Current...
3.
Li J, Hu C, Peng H, Chen E
Transl Cancer Res
. 2024 Apr;
13(3):1252-1267.
PMID: 38617505
Background: Breast cancer (BC) is the most prevalent cancer type and is the principal cause of cancer-related death in women. Anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1)...
4.
Liu M, Dai X, Zeng M, Chen E
J Neurol
. 2024 Jan;
271(6):2960-2979.
PMID: 38289535
Cryptococcal meningitis (CM) is a fatal fungal central nervous system (CNS) infection caused by Cryptococcus infecting the meninges and/or brain parenchyma, with fever, headache, neck stiffness, and visual disturbances as...
5.
Zhou J, Wang F, Li L, Li Y, Wang S, Chen E
J Clin Transl Hepatol
. 2024 Jan;
11(7):1465-1475.
PMID: 38161505
Background And Aims: Direct evidence on the outcomes of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients with normal alanine transaminase after long-term antiviral treatment is lacking. Methods:...
6.
He J, You Y, Pei X, Jiang W, Zeng Q, Chen B, et al.
Stem Cell Rev Rep
. 2023 Nov;
20(2):447-454.
PMID: 37993759
Stem cell therapy holds great promise for future clinical practice for treatment of advanced liver diseases. However, the fate of stem cells after transplantation, including the distribution, viability, and the...
7.
Wang Y, Wang M, Tao Y, Wu D, Chen E, Tang H
Stem Cell Res Ther
. 2023 Aug;
14(1):231.
PMID: 37649110
Background: Stem cells play a therapeutic role mainly through immunoregulation. However, the immunomodulatory function of stem cells may be affected by inflammation-related factors in patients' serum. Therefore, this study aims...
8.
Li L, He Y, Liu T, Zhou J, Chen E
Future Microbiol
. 2023 Jul;
18:699-705.
PMID: 37522175
Visceral leishmaniasis (VL) is a parasitic disease caused by spp., which is transmitted by sandflies. As China is not the main epidemic area and VL has complex and atypical clinical...
9.
Fan P, Li L, Chen E
Front Med (Lausanne)
. 2023 Jun;
10:1165891.
PMID: 37275355
In recent years, liver experts have conducted in-depth discussions on whether it is necessary to expand the indication of antiviral therapy for patients with chronic hepatitis B (CHB). Currently, the...
10.
Da Wang F, Zhou J, Li L, Li Y, Wang M, Tao Y, et al.
Ann Hepatol
. 2023 Jun;
28(5):101119.
PMID: 37271480
Introduction And Objectives: Renal and bone impairment has been reported in chronic hepatitis B (CHB) patients receiving long-term tenofovir disoproxil fumarate (TDF) therapy. This study aimed to assess the incidence...